Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylocaine gel versus dry speculum for Pap smear cytology adequacy
PACTR202606770457238Phase 3Not yet recruiting
- Sponsor
- Prof. Leonard Ogbonna Ajah
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lidocaine in Cervical Cancer (CC) (2 arms), sponsored by Prof. Leonard Ogbonna Ajah. Primary endpoint: Proportion of women with satisfactory Pap smear cytology in each group. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on PACTR202606770457238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202606770457238.